Development of Instrumentation for High-Rate Production of Hyperpolarized 3He Gas
超极化 3He 气体高速生产仪器的开发
基本信息
- 批准号:7257512
- 负责人:
- 金额:$ 24.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-03-01 至 2009-02-28
- 项目状态:已结题
- 来源:
- 关键词:AluminumAlveolarAmplifiersBiomedical EngineeringBiomedical ResearchBreathingCellsCharacteristicsClinicalClinical ResearchComplexComputersConditionCoupledDevelopmentDevicesDiagnosticDiffusionDimensionsElectronicsEnvironmentEnvironmental air flowEquipmentEuropeanFundingFunding MechanismsGasesGlassGuidelinesHeliumHospitalsHourHumanImageImaging TechniquesIn SituInstitutesInternetLaboratoriesLasersLifeLightLungLung diseasesMagnetic Resonance ImagingMagnetismMapsMedicineMethodsNatureNoble GasesNuclearNumbersOperating SystemOperative Surgical ProceduresOpticsPerfusionPhysiciansPhysicsPhysiologicalPhysiologyProcessProductionPumpPurposeQualifyingRateRelaxationResearchResolutionRubidiumSamplingScienceSignal TransductionStainless SteelStructureSystemTechniquesTechnologyTeflonTestingTimeUnited States National Institutes of HealthVacuumVariantWorkanalogbasebioimagingcostdesigngas analyzerinstrumentinstrumentationinterestlaptoplung imagingmagnetic fieldmultidisciplinarynovelphysical sciencepolarimetrypolyfunctional aziridinepressureprogramsprototypetechnology development
项目摘要
DESCRIPTION (provided by applicant): The broad objective of this proposal is to develop a novel, rapid, robust and portable 3He hyperpolarization apparatus that will produce ~ 1 L / hour of 3He gas spin-polarized to 40% or greater. The apparatus will use the metastability-exchange optical pumping method (MEOP), a theoretically-favorable process that has traditionally been difficult to implement. Recent advances in compressor and laser technology have overcome these hurdles. A polarizer based on the MEOP process will provide an almost ten-fold increase in production rate for hyperpolarized 3He when compared to current polarizer technology based on the alternative spinexchange optical-pumping method (SEOP). The proposed apparatus will be the first MEOP 3He hyperpolarization apparatus dedicated to biomedical MRI use in the US and which can be located in the biomedical imaging environment. This multidisciplinary program bridges the physical and biomedical sciences, with the potential to provide significant breakthrough research in pulmonary physiology and medicine. Thus this program qualifies for the R-21 funding mechanism. The Specific Aims of the program are:
1. Design and fabricate a prototype 3He hyperpolarization apparatus that operates using the metastabilityexchange optical pumping (MEOP) method, and produces ~ 1 L per hour of 40% polarized 3He gas.
2. Determine optimum operating conditions for the apparatus, studying 3He polarization signal as a function of operating parameters, including gas mixture, pressure, and compression rate.
3. Perform phantom 3He MRI studies with gas from the MEOP 3He hyperpolarization apparatus.
描述(由申请人提供):本提案的主要目标是开发一种新颖、快速、坚固且便携式的 3He 超极化装置,该装置将产生约 1 L/小时的 3He 气体,自旋极化达到 40% 或更高。该设备将使用亚稳态交换光泵浦方法(MEOP),这是一种理论上有利的过程,但传统上很难实现。压缩机和激光技术的最新进展克服了这些障碍。与当前基于替代脊柱交换光泵浦方法 (SEOP) 的偏振器技术相比,基于 MEOP 工艺的偏振器将使超偏振 3He 的生产率提高近十倍。所提出的设备将是美国第一台专门用于生物医学 MRI 的 MEOP 3He 超极化设备,并且可以放置在生物医学成像环境中。这个多学科项目连接了物理和生物医学科学,有可能在肺生理学和医学方面提供重大突破性研究。因此,该计划符合 R-21 资助机制的资格。该计划的具体目标是:
1. 设计和制造原型 3He 超极化装置,该装置使用亚稳态交换光泵浦 (MEOP) 方法运行,每小时产生约 1 L 的 40% 极化 3He 气体。
2. 确定设备的最佳操作条件,研究 3He 极化信号作为操作参数(包括气体混合物、压力和压缩率)的函数。
3. 使用来自 MEOP 3He 超极化装置的气体进行模型 3He MRI 研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RONALD L WALSWORTH其他文献
RONALD L WALSWORTH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RONALD L WALSWORTH', 18)}}的其他基金
Development of hyperpolarized silicon nanoparticles as molecular MRI agents
开发超极化硅纳米颗粒作为分子 MRI 试剂
- 批准号:
7491731 - 财政年份:2007
- 资助金额:
$ 24.17万 - 项目类别:
Development of Instrumentation for High-Rate Production of Hyperpolarized 3He Gas
超极化 3He 气体高速生产仪器的开发
- 批准号:
7362394 - 财政年份:2007
- 资助金额:
$ 24.17万 - 项目类别:
Development of hyperpolarized silicon nanoparticles as molecular MRI agents
开发超极化硅纳米颗粒作为分子 MRI 试剂
- 批准号:
7363867 - 财政年份:2007
- 资助金额:
$ 24.17万 - 项目类别:
相似国自然基金
基于“糖原合成-UDPG/P2Y14/STAT1-肺泡巨噬细胞M1型极化”途径探讨热炎宁合剂治疗急性肺损伤的作用机制
- 批准号:82374418
- 批准年份:2023
- 资助金额:51 万元
- 项目类别:面上项目
清热化痰理气方通过调控中性粒细胞导致肺泡-毛细血管单元损伤干预肺气肿形成的机制研究
- 批准号:82374361
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
去甲肾上腺素调控肺泡上皮细胞焦亡在ARDS中的作用及机制研究
- 批准号:82301442
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MUC1与BMP4相互作用影响肺泡再生和肺气肿发生发展的机制研究
- 批准号:82330002
- 批准年份:2023
- 资助金额:220 万元
- 项目类别:重点项目
Birc6泛素化调控Beclin-1在肺纤维化肺泡上皮细胞衰老中的功能及机制研究
- 批准号:82300093
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Next generation MEMS-VCSEL technology for ultra-low-cost dental and periodontal swept source optical coherence tomography imaging
用于超低成本牙科和牙周扫频光学相干断层扫描成像的下一代 MEMS-VCSEL 技术
- 批准号:
10481677 - 财政年份:2022
- 资助金额:
$ 24.17万 - 项目类别:
Inducible epithelial resistance: a program investigating mechanisms to protect against acute and chronic complications of pneumonia
诱导上皮抵抗:一项研究预防肺炎急性和慢性并发症机制的计划
- 批准号:
10359169 - 财政年份:2019
- 资助金额:
$ 24.17万 - 项目类别:
Inducible epithelial resistance: a program investigating mechanisms to protect against acute and chronic complications of pneumonia
诱导上皮抵抗:一项研究预防肺炎急性和慢性并发症机制的计划
- 批准号:
9884784 - 财政年份:2019
- 资助金额:
$ 24.17万 - 项目类别:
Inducible epithelial resistance: a program investigating mechanisms to protect against acute and chronic complications of pneumonia
诱导上皮抵抗:一项研究预防肺炎急性和慢性并发症机制的计划
- 批准号:
10614561 - 财政年份:2019
- 资助金额:
$ 24.17万 - 项目类别: